Healthcare >> CEO Interviews >> January 15, 2001
JOHN B. RUSH joined Micro Therapeutics, Inc., in May 2000 as Executive
Vice President of Marketing and Sales. He was promoted to Chief
Operating Officer in October 2000, and to President and Chief Executive
Officer in December 2000. Before he joined MTI he held the positions of
Vice President, Sales and Marketing, and General Manager at Boston
Scientific, Asia Pacific, with responsibility for sales, marketing,
finance, human resources, operations, training, and regulatory and
information systems. This organization encompassed 400 employees, was
spread throughout 15 Asian countries and generated revenues of $100
million from seven medical device divisions. Mr. Rush joined the Scimed
Life Systems division of Boston Scientific in 1990 as a Regional Sales
Manager, selling catheter-based medical devices in the cardiac
angioplasty market. In 1996, he advanced to Director of Sales, directly
supervising a 48-person sales force, which generated revenues of $120
million. Prior to his decade-long tenure at Boston Scientific, Mr. Rush
served as a Regional Sales Manager for Coopervision-Cilco (now Alcon
Surgical). He is a 1981 graduate of Philadelphia College of Pharmacy and
Science and holds a Bachelor of Science degree in Pharmacy. Profile
company's history, products and services?
Mr. Rush: Micro Therapeutics is in the business of developing,
manufacturing
